The Asia‐Pacific League of Associations for Rheumatology Consensus Recommendations on the Management of Juvenile Idiopathic Arthritis (JIA): Polyarticular Course JIA, Temporomandibular Joint Arthritis, Imaging, and Non‐Pharmacologic Therapies
International Journal of Rheumatic Diseases · 2026
DOI: 10.1111/1756-185x.70640 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2026. Verfasst von Thaschawee Arkachaisri und 34 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Immunology Service, Department of Paediatric Subspecialties, KK Women's and Children's Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Juvenile, Diagnostic Imaging, Rheumatology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: APLAR-SIG.
Abstract (Originalsprache)
Background
Juvenile idiopathic arthritis (JIA) is one of the most common childhood rheumatic diseases. In the Asia‐Pacific region, access to pediatric rheumatology services and therapies remains variable. To address regional disparities and promote evidence‐based yet practical care, the APLAR developed consensus recommendations for the management of polyarticular‐course JIA (pcJIA), temporomandibular joint (TMJ) arthritis, and non‐pharmacologic interventions.
Methods
A multidisciplinary task force of 34 members from 14 countries, including pediatric and adult rheumatologists and patient representatives, was convened. The guideline development followed the GRADE, ADAPTE, and AGREE II frameworks. Existing international guidelines were critically appraised, and a systematic literature review was performed to address 26 PICO questions. Draft statements were discussed and voted upon using a modified Delphi process, with consensus defined as ≥ 80% agreement.
Results
Four overarching principles and 32 statements were finalized: 16 for pcJIA treatment, 10 for TMJ arthritis, 3 for non‐pharmacologic therapies, 2 for imaging, and 1 for disease monitoring. Key recommendations that diverge from Western guidelines include: (1) stronger recommendation for methotrexate as initial therapy before biologic DMARDs; (2) explicit advocacy for TNF inhibitors, including biosimilars, when escalation is required; (3) cautious allowance of short‐term systemic glucocorticoids where DMARDs are limited; (4) emphasis on treat‐to‐target using cJADAS‐10; (5) stronger endorsement for physical and occupational therapy; and (6) conditional allowance of traditional and complementary medicine practices under professional supervision.
Conclusion
These consensus statements provide regionally adapted, evidence‐based recommendations to improve access, standardize management, and promote equitable care for patients with JIA across the Asia‐Pacific region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology and Immunology Service, Department of Paediatric Subspecialties, KK Women's and Children's Hospital, Singapore, Singapore.
- Division of Rheumatology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- King Faisal Specialist Hospital & Research Center, Medical College, Alfaisal University, Riyadh, Saudi Arabia.
- Selayang Hospital, Ministry of Health, Kuala Lumpur, Malaysia.
- Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
- Department of Paediatrics, Khoo Teck Puat - National University Children's Medical Institute, National University Health System, Singapore, Singapore.
ORCID-Profile: Thaschawee Arkachaisri, Kai Liang Teh, Soamarat Vilaiyuk, Sulaiman M Al-Mayouf, Swee Ping Tang, Takako Miyamae, Vahid Ziaee, Narendra Kumar Bagri, Suma Balan, Christine B Bernal, Winnie K Y Chan, Sirirat Charuvanij, Jayathri S Jagoda, Rebecca A James, Taqdees Khaliq, Saira E A Khan, Cherica A Tee, Chao-Yi Wu, Kosar Asnaashari, Pauline Chan, Ma Theresa Collante, Sern Chin Lim, Butsabong Lerkvaleekul, Watchareewan Sontichai, Leonila F Dans
Förderung
- APLAR-SIG
Zitieren
APA
Arkachaisri, T., Teh, K. L., Vilaiyuk, S., Al-Mayouf, S. M., Tang, S. P., Miyamae, T., Ang, E. Y., Ziaee, V., Bagri, N. K., Balan, S., Bernal, C. B., Chan, W. K. Y., Charuvanij, S., Campbell-Stokes, P., Ho, A. C. H., Jagoda, J. S., James, R. A., Khaliq, T., Khan, S. E. A., …, & Farman, S. (2026). The Asia‐Pacific League of Associations for Rheumatology Consensus Recommendations on the Management of Juvenile Idiopathic Arthritis (JIA): Polyarticular Course JIA, Temporomandibular Joint Arthritis, Imaging, and Non‐Pharmacologic Therapies. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70640
Vancouver
Arkachaisri T, Teh KL, Vilaiyuk S, Al-Mayouf SM, Tang SP, Miyamae T, et al. The Asia‐Pacific League of Associations for Rheumatology Consensus Recommendations on the Management of Juvenile Idiopathic Arthritis (JIA): Polyarticular Course JIA, Temporomandibular Joint Arthritis, Imaging, and Non‐Pharmacologic Therapies. International Journal of Rheumatic Diseases. 2026. doi:10.1111/1756-185x.70640
BibTeX
@article{Arkachaisri2026,
author = {Arkachaisri, Thaschawee and Teh, Kai Liang and Vilaiyuk, Soamarat and Al-Mayouf, Sulaiman M and Tang, Swee Ping and Miyamae, Takako and Ang, Elizabeth Y and Ziaee, Vahid and Bagri, Narendra Kumar and Balan, Suma and Bernal, Christine B and Chan, Winnie K Y and Charuvanij, Sirirat and Campbell-Stokes, Priscilla and Ho, Assunta C H and Jagoda, Jayathri S and James, Rebecca A and Khaliq, Taqdees and Khan, Saira E A and Tee, Cherica A and Wu, Chao-Yi and Asis, Carla M and Asnaashari, Kosar and Chan, Pauline and Celindro-Chan, Marian Crisal M and Choi, Nathalie Gail U and Collante, Ma Theresa and Huang, Junjie and Lim, Sern Chin and Lebrudo, Maria J H and Lerkvaleekul, Butsabong and Sontichai, Watchareewan and Valmonte, Mariel B and Dans, Leonila F and Farman, Sumaira},
title = {The Asia‐Pacific League of Associations for Rheumatology Consensus Recommendations on the Management of Juvenile Idiopathic Arthritis (JIA): Polyarticular Course JIA, Temporomandibular Joint Arthritis, Imaging, and Non‐Pharmacologic Therapies},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
doi = {10.1111/1756-185x.70640}
}
EUVIMED